Japan pledges $2 billion in funding for pandemic vaccine research initiative
the Strategic Center of Biomedical Advanced Vaccine Research and Development for Preparedness and Response back in March.
SCARDA's central research center will be based in Tokyo, but it will be supported by four core institutes, namely Osaka University, Nagasaki University, Hokkaido University and Chiba University. The $2 billion funding is supposed to keep it running for five years. $1.2 billion will go towards the center's vaccine research and development projects, while $400 million will be spent on supporting start-ups in drug development.
SCARDA will initially focus on developing vaccines for eight infectious diseases, including COVID-19, monkeypox, SARS, dengue and Zika virus. Its researchers will look into various types of vaccine technologies, as well, such as mRNA and viral vectors.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
How Soon After Having COVID Can You Get the New COVID Vaccine Booster Shots?If you recently had COVID-19, when is the best time to get the new omicron-specific booster shot?
Consulte Mais informação »
Can You Get Your COVID Booster And Flu Shot At The Same Time?Flu shots and the new bivalent COVID shots are now available. Here's what experts think about getting both during the same appointment.
Consulte Mais informação »
LA County lifting mask requirement for public transit, airports as COVID transmission fallsStarting today, mask requirements will be lifted in several areas across L.A. County, including public transit, correctional facilities and homeless shelters. Here's what you need to know:
Consulte Mais informação »
Over 4 Million Americans Have Been Boosted With New Omicron-Targeted COVID ShotHealth experts said it is too early to predict whether demand would match up with the 171 million doses of the new boosters the U.S. ordered for the fall.
Consulte Mais informação »
4.4M Americans have received new omicron-targeted COVID-19 booster, CDC saysSome Americans who plan to get the shot, designed to target the most common omicron strains, said they are waiting because they either had COVID-19 recently or another booster.
Consulte Mais informação »